TY - JOUR
T1 - Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria
AU - Fjellstedt, E
AU - Denneberg, T
AU - Jeppsson, J O
AU - Christensson, A
AU - Tiselius, H G
PY - 2001/10
Y1 - 2001/10
N2 - Based on previous observations of the diurnal variation of urinary cystine excretion, the use of separate day and night urine collections was proposed. To improve the medical treatment of patients with cystinuria, this strategy was performed to guide the fluid intake and the administration of SH compounds (tiopronin, D-penicillamine, and MESNA).Twenty-six patients (19 treated with SH compounds and seven with alkalinization and hydration only) were followed during two 3.5-year periods. During Period 1, 24-h urine was collected and during Period 2, separate day and night urine was collected. There were 56 episodes of high urinary cystine supersaturation (> 1,200 micromol/l) during Period 2, 47% of which would have evaded detection with 24-h urine analysis. In comparison with Period 1, the urinary cystine concentration was lower (P < 0.05), and the urinary volume was higher (P < 0.05) during Period 2. Patients treated with tiopronin had reduced cystine excretion (P < 0.05) and at the end of Period 2, an increased dose of tiopronin, reflecting a more aggressive treatment. Furthermore, a reduced number of stone episodes and need of active stone removal (P < 0.05) was noted in the whole group of patients. Analyses of separate day and night urine samples can be used advantageously to reveal episodes of high supersaturation with cystine not detected in 24-h urine samples. Such a procedure might be useful for optimizing the treatment of patients with cystinuria.
AB - Based on previous observations of the diurnal variation of urinary cystine excretion, the use of separate day and night urine collections was proposed. To improve the medical treatment of patients with cystinuria, this strategy was performed to guide the fluid intake and the administration of SH compounds (tiopronin, D-penicillamine, and MESNA).Twenty-six patients (19 treated with SH compounds and seven with alkalinization and hydration only) were followed during two 3.5-year periods. During Period 1, 24-h urine was collected and during Period 2, separate day and night urine was collected. There were 56 episodes of high urinary cystine supersaturation (> 1,200 micromol/l) during Period 2, 47% of which would have evaded detection with 24-h urine analysis. In comparison with Period 1, the urinary cystine concentration was lower (P < 0.05), and the urinary volume was higher (P < 0.05) during Period 2. Patients treated with tiopronin had reduced cystine excretion (P < 0.05) and at the end of Period 2, an increased dose of tiopronin, reflecting a more aggressive treatment. Furthermore, a reduced number of stone episodes and need of active stone removal (P < 0.05) was noted in the whole group of patients. Analyses of separate day and night urine samples can be used advantageously to reveal episodes of high supersaturation with cystine not detected in 24-h urine samples. Such a procedure might be useful for optimizing the treatment of patients with cystinuria.
KW - Adult
KW - Aged
KW - Circadian Rhythm
KW - Cystinuria/genetics
KW - Dose-Response Relationship, Drug
KW - Female
KW - Homozygote
KW - Humans
KW - Male
KW - Mesna/therapeutic use
KW - Middle Aged
KW - Osmolar Concentration
KW - Penicillamine/therapeutic use
KW - Specimen Handling/methods
KW - Sulfhydryl Compounds/therapeutic use
KW - Tiopronin/administration & dosage
KW - Urinary Calculi/prevention & control
UR - https://www.scopus.com/pages/publications/0035155658
U2 - 10.1007/s002400100201
DO - 10.1007/s002400100201
M3 - Article
C2 - 11762791
SN - 0300-5623
VL - 29
SP - 303
EP - 310
JO - Urological Research
JF - Urological Research
IS - 5
ER -